"More virus, more vaccine and more treatment," is how the director of the Centers for Disease Control and Prevention summed up the current situation with H1N1 influenza.

Thomas Frieden, MD, said laboratory-confirmed pediatric deaths in the U.S. are up to 114 -- an increase of 19 over the past week. About two-thrids of those deaths involved children with underlying medical conditions.

Frieden said the federal government is releasing the remaining 234 thousand courses of children's liquid Tamiflu from its Strategic National Stockpile. The SNS had already released 300 thousand courses of the anti-viral drug amid reports of sporadic shortages at pharmacies.

The CDC is offering guidance to pharmacists on how to break down adult Tamiflu capsules into pediatric doses and mix them with a syrup to make them palatable for children.

Frieden said parents can break down child capsules and mix them with chocolate or some other tasty syrup "to make the medicine go down." But he cautioned parents against attempting to convert adult sized tablets into pediatric doses -- a procedure called "compounding," which Frieden said should only be done by licensed pharmacists.

H1N1 continues to be a younger person's flu with 90 percent of fatal cases involving persons under 65. With seasonal flu, 90 percent of the deaths involve persons over 65.

While H1N1 vaccine supplies are still considerably lower than manufacturers had predicted, 26.6 million doses are now available for shipment -- a 10.5 million dose increase over this time last week.